Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage

American Journal of Pathology

Volumn 165, Issue 5, 2004, Pages 1603-1612

  Kawai, Hanayo ^a   Sato, Waichi ^a   Yuzawa, Yukio ^a   Kosugi, Tomoki ^a   Matsuo, Seiichi ^a   Takei, Yoshifumi ^a   Kadomatsu, Kenji ^a   Muramatsu, Takashi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CISPLATIN; MIDKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CHEMOTAXIS; CONTROLLED STUDY; EPITHELIUM CELL; INFLAMMATION; KIDNEY INJURY; KIDNEY TUBULE; MOLECULAR BIOLOGY; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL; SURVIVAL RATE; TISSUE DEGENERATION; UREA NITROGEN BLOOD LEVEL; WILD TYPE;

EID: 7244248552     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63417-7     Document Type: Article

References (38)

1. Kuhlmann MK, Burkhardt G, Köhler H: Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 1997, 12:2478-2480
2. Leibbrandt ME, Wolfgang GH, Metz AL, Ozobia AA, Haskins JR: Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells. Kidney Int 1995, 48:761-770
3. Rosenberg JM, Sato PH: Cisplatin inhibits in vitro translation by preventing the formation of complete initiation complex. Mol Pharmacol 1993, 43:491-497
4. Courjault-Gautier F, Le Grimellec C, Giocondi MC, Toutain HJ: Modulation of sodium-coupled uptake and membrane fluidity by cisplatin in renal proximal tubular cells in primary culture and brush-border membrane vesicles. Kidney Int 1995, 47:1048-1056
5. Bompart G: Cisplatin-induced changes in cytochrome P-450, lipid peroxidation and drug-metabolizing enzyme activities in rat kidney cortex. Toxicol Lett 1989, 48:193-199
6. Mistry P, Merazga Y, Spargo DJ, Riley PA, McBrien DC: The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother Pharmacol 1991, 28:277-282
7. Zhang JG, Lindup WE: Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem Pharmacol 1993, 45:2215-2222
8. Kelly KJ, Meehan SM, Colvin RB, Williams WW, Bonventre JV: Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody. Kidney Int 1999, 56:922-931
9. Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, Miyaji T, McLeroy P, Nibhanupudy B, Li S, Star RA: Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 2001, 60:2118-2128
10. Ramesh G, Reeves WB: TNF-alpha mediates chemoklne and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002, 110:835-842
11. Muramatsu T: Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem (Tokyo) 2002, 132:359-371
12. Kurtz A, Schulte AM, Wellstein A: Pleiotrophin and midkine in normal development and tumor biology. Crit Rev Oncol 1995, 6:151-177
13. Vilar J, Lalou C, Duong VH, Charrin S, Hardouin S, Raulais D, Merlet-Bénichou C, Leliévre-Pégorier M: Midkine is involved in kidney development and in its regulation by retinoids. J Am Soc Nephrol 2002, 13:668-676
14. Kadomatsu K, Tomomura M, Muramatsu T: cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 1988, 151:1312-1318
15. Kadomatsu K, Huang RP, Suganuma T, Murata F, Muramatsu T: A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J Cell Biol 1990, 110:607-616
16. Mitsiadis TA, Muramatsu T, Muramatsu H, Thesleff I: Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis. J Cell Biol 1995, 129:267-281
17. Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S, Muramatsu T: Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 2001, 167:3463-3469
18. Qi M, Ikematsu S, Ichihara-Tanaka K, Sakuma S, Muramatsu T, Kadomatsu K: Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by midkine. J Biochem (Tokyo) 2000, 127:269-277
19. Owada K, Sanjo N, Kobayashi T, Mizusawa H, Muramatsu H, Muramatsu T, Michikawa M: Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J Neurochem 1999, 73:2084-2092
20. Takada T, Toriyama K, Muramatsu H, Song XJ, Torii S, Muramatsu T: Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J Biochem (Tokyo) 1997, 122:453-458
21. Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S, Hayashi K, Yuzawa Y, Matsuo S, Kuzuya M, Kaname T, Hirai M, Saito H, Muramatsu T: Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest 2000, 105:489-495
22. Qi M, Ikematsu S, Maeda N, Ichihara-Tanaka K, Sakuma S, Noda M, Muramatsu T, Kadomatsu K: Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase. J Biol Chem 2001, 276:15868-15875
23. Unoki K, Ohba N, Arimura H, Muramatsu H, Muramatsu T: Rescue of photoreceptors from the damaging effects of constant light by midkine, a retinoic acid-responsive gene product. Invest Ophthalmol Vis Sci 1994, 35:4063-4068
24. Yoshida Y, Ikematsu S, Moritoyo T, Goto M, Tsutsui J, Sakuma S, Osame M, Muramatsu T: Intraventricular administration of the neurotrophic factor midkine ameliorates hippocampal delayed neuronal death following transient forebrain ischemia in gerbils. Brain Res 2001, 894:46-55
25. Kadomatsu K, Hagihara M, Akhter S, Fan QW, Muramatsu H, Muramatsu T: Midkine induces the transformation of NIH3T3 cells. Br J Cancer 1997, 75:354-359
26. Nakamura E, Kadomatsu K, Yuasa S, Muramatsu H, Mamiya T, Nabeshima T, Fan QW, Ishiguro K, Igakura T, Matsubara S, Kaname T, Horiba M, Saito H, Muramatsu T: Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. Genes Cells 1998, 3:811-822
27. Nomura A, Nishikawa K, Yuzawa Y, Okada H, Okada N, Morgan BP, Piddlesden SJ, Nadai M, Hasegawa T, Matsuo S: Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. J Clin Invest 1995, 96:2348-2356
28. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, Kelley VE: MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 1990, 37:783-792
29. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ: Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997, 91:649-659
30. Kadomatsu K, Anzano MA, Slayter MV, Winokur TS, Smith JM, Sporn MB: Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle. Cancer Res 1993, 53:1480-1483
31. Takei Y, Kadomatsu K, Matsuo S, Itoh H, Nakazawa K, Kubota S, Muramatsu T: Antisense oligodeoxynucleotide targeted to midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells. Cancer Res 2001, 61:8486-8491
32. Ishikawa T, Ali-Osman F: Glutathione-associated cis- diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J Biol Chem 1993, 268:20116-20125
33. Bernareggi A, Torti L, Facino RM, Carini M, Depta G, Casetta B, Farrell N, Spadacini S, Ceserani R, Tognella S: Characterization of dsplatin-glutathione adducts by liquid chromatography-mass spectrometry. Evidence for their formation in vitro but not in vivo after concomitant administration of cisplatin and glutathione to rats and cancer patients. J Chromatogr B Biomed Appl 1995, 669:247-263
34. Townsend DM, Deng M, Zhang L, Lapus MG, Hanigan MH: Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 2003, 14:1-10
35. Hanigan MH, Lykissa ED, Townsend DM, Ou CN, Barrios R, Lieberman MW: Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin. Am J Pathol 2001, 159:1889-1894
36. Sheridan AM, Bonventre JV: Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 2000, 9:427-434
37. Oberbauer R, Schreiner GF, Meyer TW: Renal uptake of an 18-mer phosphorothioate oligonucleotide. Kidney Int 1995, 48:1226-1232
38. Oberbauer R, Schreiner GF, Biber J, Murer H, Meyer TW: In vivo suppression of the renal Na+/Pi cotransporter by antisense oligonucleotides. Proc Natl Acad Sci USA 1996, 93:4903-4906